David E Beck1, David A Margolin1, Sheena Farragut Babin2, Christine Theriot Russo2. 1. Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, LA ; The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA. 2. Department of Pharmacy, Ochsner Clinic Foundation, New Orleans, LA.
Abstract
BACKGROUND: Postoperative pain management is a major concern and a significant component of postoperative care pathways for surgery patients. METHODS: We performed a retrospective medical record review of 233 consecutive patients undergoing major colorectal surgery from October 2011 to January 2013 at an academic medical center. All patients were managed with similar enhanced recovery pathways; 66 patients received multimodal postsurgical pain management that included liposomal bupivacaine intraoperatively, and 167 patients received conventional pain management with intravenous opioids. Comparisons were made using t test and chi-square analysis with StatView (SAS Institute Inc.). RESULTS: Patients receiving multimodal pain management with liposomal bupivacaine injected in the surgical site at the end of major colorectal procedures had lower postoperative pain scores and used significantly less opioids at 12, 24, 36, 48, 60, and 72 hours (P=0.03). Patients in the multimodal group also had a significantly decreased risk of opioid-related adverse events, with decreased use of antipruritic medications and antiemetic medications postoperatively. A significant decrease in length of postoperative hospital stay was seen in the multimodal group (7.2 vs 9.0 days, P=0.04). CONCLUSION: The use of multimodal pain management including liposomal bupivacaine during major colorectal surgeries improved postoperative outcomes, decreased lengths of stay, and increased bed availability.
BACKGROUND:Postoperative pain management is a major concern and a significant component of postoperative care pathways for surgery patients. METHODS: We performed a retrospective medical record review of 233 consecutive patients undergoing major colorectal surgery from October 2011 to January 2013 at an academic medical center. All patients were managed with similar enhanced recovery pathways; 66 patients received multimodal postsurgical pain management that included liposomal bupivacaine intraoperatively, and 167 patients received conventional pain management with intravenous opioids. Comparisons were made using t test and chi-square analysis with StatView (SAS Institute Inc.). RESULTS:Patients receiving multimodal pain management with liposomal bupivacaine injected in the surgical site at the end of major colorectal procedures had lower postoperative pain scores and used significantly less opioids at 12, 24, 36, 48, 60, and 72 hours (P=0.03). Patients in the multimodal group also had a significantly decreased risk of opioid-related adverse events, with decreased use of antipruritic medications and antiemetic medications postoperatively. A significant decrease in length of postoperative hospital stay was seen in the multimodal group (7.2 vs 9.0 days, P=0.04). CONCLUSION: The use of multimodal pain management including liposomal bupivacaine during major colorectal surgeries improved postoperative outcomes, decreased lengths of stay, and increased bed availability.
Entities:
Keywords:
Bupivacaine; combined modality therapy; pain management; postoperative care
Authors: Kristoffer Lassen; Mattias Soop; Jonas Nygren; P Boris W Cox; Paul O Hendry; Claudia Spies; Maarten F von Meyenfeldt; Kenneth C H Fearon; Arthur Revhaug; Stig Norderval; Olle Ljungqvist; Dileep N Lobo; Cornelis H C Dejong Journal: Arch Surg Date: 2009-10
Authors: Freek Gillissen; Christiaan Hoff; José M C Maessen; Bjorn Winkens; Jitske H F A Teeuwen; Maarten F von Meyenfeldt; Cornelis H C Dejong Journal: World J Surg Date: 2013-05 Impact factor: 3.352
Authors: Marko Tomov; Kevin Tou; Rose Winkel; Ross Puffer; Mohamad Bydon; Ahmad Nassr; Paul Huddleston; Michael Yaszemski; Bradford Currier; Brett Freedman Journal: Asian Spine J Date: 2018-02-07
Authors: Alberto A Uribe; Fernando L Arbona; David C Flanigan; Christopher C Kaeding; Marilly Palettas; Sergio D Bergese Journal: Front Surg Date: 2018-10-03